🔎 Trials Near Me

Home › Neuroblastoma › Missouri

Pag-aaral pangklinika para sa Neuroblastoma sa Missouri

10 pag-aaral para sa Neuroblastoma ang naghahanap ng mga kalahok sa mga site sa Missouri.

Mga Lungsod sa Missouri

Opisyal na teksto ng pag-aaral (English)

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

  • University of Missouri Children's Hospital, Columbia
  • Children's Mercy Hospitals and Clinics, Kansas City
  • Washington University School of Medicine, St Louis
  • at 1 pa
Nagre-recruitPhase 3
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 24, 2026 · NCT06172296

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

  • Children's Mercy Hospital ( Site 1024), Kansas City
Nagre-recruitPhase 1/2
6 Months – 25 Years · Lahat ng kasarian · Na-update Set 17, 2026 · NCT06395103

Pediatric Precision Laboratory Advanced Neuroblastoma Therapy

  • Cardinal Glennon Children's Medical Center, St Louis
Nagre-recruitPhase 2
Hanggang edad 22 · Lahat ng kasarian · Na-update Set 4, 2026 · NCT02559778

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

  • Cardinal Glennon Children's Medical Center, St Louis
Nagre-recruitPhase 1/2
Hanggang edad 26 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06465199

Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors

  • Children's Mercy Hospitals and Clinics, Kansas City
  • Cardinal Glennon Children's Medical Center, St Louis
Nagre-recruitPhase 1/2
Hanggang edad 30 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06541262

Tipifarnib and Naxitamab for Relapsed/Refractory Neuroblastoma

  • Cardinal Glennon Children's Medical Center, St Louis
Nagre-recruitPhase 2
Edad 1 hanggang 21 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06540963

Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

  • University of Missouri Children's Hospital, Columbia
  • Children's Mercy Hospitals and Clinics, Kansas City
  • Washington University School of Medicine, St Louis
  • at 1 pa
Nagre-recruitPhase 3
365 Days – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT03126916

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Washington University School of Medicine, St Louis
Nagre-recruitPhase 1/2
12 Months – 30 Years · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04851119

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

  • Cardinal Glennon Children's Hospital, St Louis
Nagre-recruitPhase 2
12 Months – 21 Years · Lahat ng kasarian · Na-update Ago 12, 2026 · NCT05489887

SPEARHEAD-3 Pediatric Study

  • Washington University, St Louis
Nagre-recruitPhase 1/2
Edad 2 hanggang 21 · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05642455

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.